Corina Taitt

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

David A. Reardon, Alba A. Brandes, Antonio Omuro et al. · JAMA Oncology · 2020 · 1.5K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

Alexander M.M. Eggermont, Vanna Chiarion‐Sileni, Jean‐Jacques Grob et al. · New England Journal of Medicine · 2016 · 1.3K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies

Charles A. Powell, Shanu Modi, Hiroji Iwata et al. · ESMO Open · 2022 · 231 citations · Full text

Medicine, Oncology, Pharmacology +12

Expression of LAG‐3 and efficacy of combination treatment with anti‐LAG‐3 and anti‐PD‐1 monoclonal antibodies in glioblastoma

Sarah Harris‐Bookman, Dimitrios Mathios, Allison Martin et al. · International Journal of Cancer · 2018 · 159 citations · Full text

Life Sciences, Immunology, Oncology +17

289P Risk factors for interstitial lung disease in patients treated with trastuzumab deruxtecan from two interventional studies

Charles A. Powell, D. Ross Camidge, Shanu Modi et al. · Annals of Oncology · 2020 · 21 citations

Medicine, Clinical Sciences, Oncology +8